Application of levorotatory tetrahydropalmatine to the treatment of depression disorders, bipolar and related disorders, and manic episodes
US10842788B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 19, 2019 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Jul 19, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compound levorotatory-tetrahydropalmatine and pharmaceutical compositions thereof are provided for the treatment of ‘depressant disorders’, ‘bipolar and related disorders’, ‘manic episodes’ and ‘anxiety disorders’ as these disorders are defined in Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.